Astrana Health Return on Tangible Equity 2016-2025 | ASTH
Current and historical return on tangible equity values for Astrana Health (ASTH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Astrana Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-12-31 | $0.02B | $-0.06B | -38.10% |
| 2025-09-30 | $0.01B | $0.07B | 12.37% |
| 2025-06-30 | $0.03B | $0.21B | 11.89% |
| 2025-03-31 | $0.04B | $0.19B | 18.69% |
| 2024-12-31 | $0.04B | $0.16B | 26.26% |
| 2024-09-30 | $0.06B | $0.19B | 33.42% |
| 2024-06-30 | $0.07B | $0.20B | 34.04% |
| 2024-03-31 | $0.06B | $0.22B | 28.74% |
| 2023-12-31 | $0.06B | $0.24B | 25.56% |
| 2023-09-30 | $0.04B | $0.22B | 20.21% |
| 2023-06-30 | $0.05B | $0.20B | 22.33% |
| 2023-03-31 | $0.04B | $0.19B | 23.75% |
| 2022-12-31 | $0.05B | $0.17B | 26.32% |
| 2022-09-30 | $0.06B | $0.15B | 37.97% |
| 2022-06-30 | $0.07B | $0.14B | 51.02% |
| 2022-03-31 | $0.07B | $0.12B | 59.57% |
| 2021-12-31 | $0.07B | $0.09B | 78.86% |
| 2021-09-30 | $0.07B | $0.06B | 121.74% |
| 2021-06-30 | $0.05B | $0.00B | 1247.06% |
| 2021-03-31 | $0.05B | $-0.05B | -96.91% |
| 2020-12-31 | $0.04B | $-0.09B | -42.22% |
| 2020-09-30 | $0.04B | $-0.13B | -27.24% |
| 2020-06-30 | $0.02B | $-0.14B | -15.36% |
| 2020-03-31 | $0.02B | $-0.15B | -13.13% |
| 2019-12-31 | $0.02B | $-0.13B | -11.41% |
| 2019-09-30 | $0.01B | $-0.12B | -4.27% |
| 2019-06-30 | $0.01B | $-0.10B | -9.90% |
| 2019-03-31 | $0.01B | $-0.10B | -9.42% |
| 2018-12-31 | $0.01B | $-0.10B | -10.63% |
| 2018-09-30 | $0.04B | $-0.11B | -36.28% |
| 2018-06-30 | $0.04B | $-0.09B | -42.58% |
| 2018-03-31 | $0.04B | $-0.06B | -59.92% |
| 2017-12-31 | $0.04B | $-0.03B | -118.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |